Ilmarinen Mutual Pension Insurance Co Purchases 7,200 Shares of Intuitive Surgical, Inc. $ISRG

Ilmarinen Mutual Pension Insurance Co lifted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 13.1% in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 62,000 shares of the medical equipment provider’s stock after acquiring an additional 7,200 shares during the quarter. Ilmarinen Mutual Pension Insurance Co’s holdings in Intuitive Surgical were worth $25,211,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in ISRG. Bank of New York Mellon Corp purchased a new position in shares of Intuitive Surgical during the second quarter valued at $1,335,753,000. Arrowstreet Capital Limited Partnership raised its position in Intuitive Surgical by 95.3% during the first quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider’s stock valued at $970,635,000 after buying an additional 1,027,475 shares during the period. Assenagon Asset Management S.A. raised its position in Intuitive Surgical by 55.8% during the third quarter. Assenagon Asset Management S.A. now owns 1,557,940 shares of the medical equipment provider’s stock valued at $633,505,000 after buying an additional 558,099 shares during the period. Mirae Asset Global Investments Co. Ltd. purchased a new stake in Intuitive Surgical in the 3rd quarter worth about $136,743,000. Finally, Voya Investment Management LLC lifted its stake in Intuitive Surgical by 97.2% in the 3rd quarter. Voya Investment Management LLC now owns 491,914 shares of the medical equipment provider’s stock worth $200,028,000 after acquiring an additional 242,468 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Trading Down 2.0%

ISRG opened at $399.06 on Friday. The stock has a fifty day moving average price of $423.51 and a 200 day moving average price of $427.91. Intuitive Surgical, Inc. has a 1 year low of $328.57 and a 1 year high of $603.88. The stock has a market cap of $138.33 billion, a price-to-earnings ratio of 48.25, a PEG ratio of 3.02 and a beta of 1.45.

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last issued its earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share for the quarter, topping the consensus estimate of $2.65 by $0.35. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The company had revenue of $3.05 billion for the quarter, compared to analyst estimates of $2.91 billion. During the same period in the prior year, the firm posted $2.40 EPS. The business’s revenue was up 21.7% compared to the same quarter last year. As a group, sell-side analysts forecast that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, EVP Mark Brosius sold 61 shares of the business’s stock in a transaction that occurred on Wednesday, October 28th. The stock was sold at an average price of $441.60, for a total value of $26,937.60. Following the completion of the sale, the executive vice president owned 581 shares of the company’s stock, valued at approximately $256,569.60. The trade was a 9.50% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Craig Barratt sold 1,150 shares of the stock in a transaction that occurred on Wednesday, November 4th. The stock was sold at an average price of $460.00, for a total value of $529,000.00. Following the completion of the transaction, the director owned 1,150 shares in the company, valued at $529,000. This represents a 50.00% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 39,363 shares of company stock worth $17,738,749 in the last quarter. Corporate insiders own 0.60% of the company’s stock.

Intuitive Surgical News Roundup

These are some of the ISRG news items that stood out recently:

  • Positive Sentiment: A BTIG Research analyst reportedly expects ISRG shares to rise, providing a positive analyst signal; the headline does not specify a price target or the reasoning. BTIG analyst article
  • Positive Sentiment: Industry coverage casts Intuitive Surgical as a leading beneficiary of expanding surgical-robotics adoption, citing growth in robotic procedures and use of its da Vinci system. A separate medical-device roundup also identifies ISRG as a stock to watch, though neither story reports a new company announcement. Surgical robotics industry article Medical-device stocks article
  • Neutral Sentiment: An executive sold 46 shares under a pre-arranged Rule 10b5-1 plan. The transaction was small and scheduled in advance, so it is a limited signal about management’s outlook. Insider-sale report

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on ISRG shares. Wall Street Zen raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Saturday, October 31st. BTIG Research upped their target price on Intuitive Surgical from $454.00 to $513.00 and gave the company a “buy” rating in a report on Wednesday. Wells Fargo & Company reissued an “overweight” rating and issued a $486.00 price target (down from $487.00) on shares of Intuitive Surgical in a research report on Wednesday, October 21st. JPMorgan Chase & Co. raised their price target on shares of Intuitive Surgical from $450.00 to $475.00 and gave the stock an “overweight” rating in a report on Wednesday, October 21st. Finally, Robert W. Baird raised their price target on shares of Intuitive Surgical from $513.00 to $550.00 and gave the stock an “outperform” rating in a report on Wednesday, October 21st. One analyst has rated the stock with a Strong Buy rating, twenty-three have given a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $495.90.

Read Our Latest Stock Report on Intuitive Surgical

Intuitive Surgical Profile

(Free Report)

Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.

Featured Stories

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.